Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study in HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy in Plasma, After a Change in HIV Treatment With an Increased of CHARTER Score ≥ 3 (Total Score ≥ 9)

NCT04266002 is registered in ClinicalTrials.gov with Hôpital Franco-Britannique-Fondation Cognacq-Jay as lead sponsor.

NCT NCT04266002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04266002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study in HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy in Plasma, After a Change in HIV Treatment With an Increased of CHARTER Score ≥ 3 (Total Score ≥ 9)
Lead sponsor
Hôpital Franco-Britannique-Fondation Cognacq-Jay
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2011
Completion date
July 26, 2016
Enrollment
31 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hiv associated neurocognitive disorder, hiv-1-infection